|
 |
A strong supply chain is
essential to support Indian Medical Device Industry in order to accelerate the
“Make-in-India” process. However, it is also essential that the companies select
potential suppliers, contractors and service providers with due care. After all,
Medical Device Company - not the supplier - is responsible for complying with
regulations and standards. Choosing the right vendors and managing them
effectively can increase a manufacturer’s efficiency in terms of time, cost and
quality. This issue
highlights critical issues related to effective Vendor Management for Medical
Device Industry. We highly appreciate Ms Priti Vani, Plant Head, Sahajanand
Laser Technology Ltd for contributing an article on “Supplier Quality
Management” and sharing her knowledge and experience with our readers. We appeal
all the Executives of Indian Medical Device Industry to come forward and
contributes articles related to their areas of specialization. |
|
Strengthening the Ecosystem for Innovations, Growth
and sustainability is the need of the hour for Indian Medical Device Industry.
Creation of Medical Device Parks in the country is an important requirement for
strengthening the ecosystem. Governments of Andhra Pradesh and Gujarat have
taken active steps in the direction. “Andhra Med Tech Zone, ( AMTZ )” will be
Asia’s first dedicated Medical Device Park to be established in an area of 226
acres at Vishakhapatnam in Andhra Pradesh. AMTZ is the brain child of Dr
Jitendar Sharma, Head, Health Technology Dept., National Health Systems Resource
Centre and advisor to Chief Minister of Andhra Pradesh for Health and Medical
Technology. Government of Gujarat has also allocated land for setting up Medical
Device Park at Sanand. As per Dr H G Koshia, Commissioner, FDCA Gujarat State,
“Medical Device Park is very relevant for Gujarat as the state has 135 licensed
Medical Device Companies as against 240 in the entire country”. As per Dr Koshia,
“setting up of this park will bring about quality, compliance and cost
effectiveness”.
On the regulatory front also, there are many
developments. After the development of ICMED, the country’s first indigenously
developed quality assurance system, a joint initiative of AIMED and Quality
Council of India, the Industry now wants ICMED Certification mandatory for all
Medical Devices marketed in India. The Government of India has also agreed to
align Schedule M III with ISO 13485 by delinking it from Schedule M for
Pharmaceuticals industry. The revised Schedule M III is expected to be notified
by end June 2016. The recently announced new IPR Policy is also expected to spur
Innovation in Med – Tech Sector.
D.L. Pandya
|
